CTI BioPharma Corp. (CTIC)
NASDAQ: CTIC
· Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM
CTI BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 24.12M | 21.08M | 18.24M | 12.33M | 2.29M | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.22M | 1.17M | 1.15M | 917K | 278K | n/a | n/a | n/a | n/a |
Gross Profit | 22.89M | 19.92M | 17.09M | 11.41M | 2.02M | n/a | n/a | n/a | n/a |
Operating Income | -9.23M | -13.6M | -12.22M | -18.88M | -35.1M | -35.37M | -23.38M | -19.51M | -17.07M |
Interest Income | 866K | 1.02M | 435K | 212K | 15K | 10K | 9K | 8K | 11K |
Pretax Income | -13.42M | -17.46M | -15.71M | -22.65M | -37.17M | -36.79M | -24.18M | -19.68M | -17.27M |
Net Income | -21.8M | -16.93M | -15.63M | -22.66M | -37.19M | -38.21M | -24.18M | -19.68M | -17.27M |
Selling & General & Admin | 21.91M | 23.69M | 21.5M | 21.59M | 18.05M | 24.69M | 13.66M | 10.21M | 7.63M |
Research & Development | 10.21M | 11.92M | 8.22M | 8.71M | 8.05M | 10.68M | 9.72M | 9.29M | 9.44M |
Other Expenses | n/a | -2.1M | -411K | n/a | 11.02M | n/a | n/a | n/a | n/a |
Operating Expenses | 32.12M | 33.51M | 29.31M | 30.3M | 37.12M | 35.38M | 23.38M | 19.51M | 17.07M |
Interest Expense | 5.05M | 3.75M | 4M | 3.97M | 2.08M | 1.42M | 662K | 175K | 198K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 6.85M | n/a | n/a | n/a |
Cost & Expenses | 33.35M | 34.68M | 30.46M | 31.21M | 37.4M | 35.38M | 23.38M | 19.51M | 17.07M |
Income Tax Expense | 8.37M | -532K | -77K | 10K | 12K | 1.42M | -136K | 6K | 2K |
Shares Outstanding (Basic) | 131.57M | 128.43M | 121.6M | 108.53M | 99.83M | 97.66M | 93.82M | 92.34M | 76.37M |
Shares Outstanding (Diluted) | 131.57M | 128.43M | 121.6M | 108.53M | 99.83M | 97.66M | 93.82M | 92.34M | 76.37M |
EPS (Basic) | -0.17 | -0.13 | -0.13 | -0.21 | -0.37 | -0.39 | -0.26 | -0.21 | -0.23 |
EPS (Diluted) | -0.17 | -0.13 | -0.13 | -0.21 | -0.37 | -0.39 | -0.26 | -0.21 | -0.23 |
EBITDA | -7.85M | -13.71M | -11.25M | -18.1M | -34.77M | 59.56M | -23.38M | -19.37M | -16.93M |
EBIT | -8.37M | -13.71M | -11.71M | -18.68M | -35.1M | -130.7M | -23.52M | -19.5M | -17.07M |
Depreciation & Amortization | 1.39M | -111K | 967K | 782K | 332K | 131K | 132K | 128K | 135K |